Open access · CC-BY
via OpenAlex
A Mendelian randomization-based risk model using aging-related genes for prognosis in lung adenocarcinoma
Shaowen Feng, Xiaowang Liu, Huiqin Yang, Jiazheng Huang, Ziang Wang, Hui Li, Jiahao Cai, Zhonghe Liu
Discover Oncology · 2025
Abstract
BACKGROUND: Aging-related genes (ARGs) are prognostic markers in cancers, but their role in lung adenocarcinoma (LUAD) remains unclear. Investigating ARGs in LUAD may provide valuable insights for clinical diagnosis and treatment. METHODS: Gene expression profiles from TCGA and GEO datasets were analyzed to identify ARG-related genes. Univariate Cox regression and LASSO analysis were used to construct a prognostic risk model. Kaplan-Meier survival analysis, ROC curves, and clinicopathological features validated its predictive accuracy. Immune cell infiltration and tumor microenvironment were assessed using CIBERSORT and ESTIMATE. RT-qPCR was used to validate the differential expression of key genes in LUAD and adjacent normal tissues. RESULTS: Seven prognostic ARGs (RHPN2, BLK, PTPRO, CA4, UBE2C, METTL7A, and H2BC12) were identified. The risk model stratified patients into high- and low-risk groups, with high-risk individuals showing poorer survival, increased immune evasion, and altered immune cell infiltration. These findings were validated in independent datasets. RT-qPCR confirmed elevated RHPN2, BLK, UBE2C, and H2BC12 in tumors, while PTPRO, CA4, and METTL7A were reduced. CONCLUSION: A robust ARG-based risk model, leveraging Cox regression and LASSO, effectively predicts survival and immunotherapy responses in LUAD, offering new tools for personalized prognosis and treatment strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s12672-025-04101-x
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Feng, S., Liu, X., Yang, H., Huang, J., Wang, Z., Li, H., Cai, J., & Liu, Z. (2025). A Mendelian randomization-based risk model using aging-related genes for prognosis in lung adenocarcinoma. <em>Discover Oncology</em>. https://doi.org/10.1007/s12672-025-04101-x
Vancouver
Feng S, Liu X, Yang H, Huang J, Wang Z, Li H, et al. A Mendelian randomization-based risk model using aging-related genes for prognosis in lung adenocarcinoma. Discover Oncology. 2025. doi:10.1007/s12672-025-04101-x.
BibTeX
@article{shaowen2025AMende,
title = {A Mendelian randomization-based risk model using aging-related genes for prognosis in lung adenocarcinoma},
author = {Shaowen Feng and Xiaowang Liu and Huiqin Yang and Jiazheng Huang and Ziang Wang and Hui Li and Jiahao Cai and Zhonghe Liu},
journal = {Discover Oncology},
year = {2025},
doi = {10.1007/s12672-025-04101-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC cancer 2026
Open access · OA
Integrated analysis identifies an aging-related prognostic signature for lung adenocarcinoma.
Frontiers in Immunology 2024
Open access · CC-BY
Exploring the molecular and immune landscape of cellular senescence in lung adenocarcinoma
Scientific Reports 2024
Open access · CC-BY
Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis
Cellular Oncology 2021
Open access · CC-BY
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing
World Journal of Gastrointestinal Oncology 2024
Open access · CC-BY
Hepatocellular carcinoma: An analysis of the expression status of stress granules and their prognostic value
Current Gene Therapy 2025
Open access · CC-BY